Pharmena S.A. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was PLN 10.78 million compared to PLN 7.38 million a year ago. Net loss was PLN 3.09 million compared to PLN 3.42 million a year ago. Basic loss per share from continuing operations was PLN 0.28 compared to PLN 0.31 a year ago. Diluted loss per share from continuing operations was PLN 0.28 compared to PLN 0.31 a year ago.